Pfizer: Anthony J. Coyle to head Global Centers for Therapeutic Innovation
Dr. Coyle brings extensive knowledge of the full drug development process to this initiative. As vice president, research and development, and head, inflammation and autoimmunity research, Anthony J. Coyle, Ph.D., oversees MedImmune's preclinical research in disease areas such as asthma, lupus, rheumatoid arthritis and sepsis.
Prior to joining MedImmune as a senior director in 2005, Dr. Coyle served as director, inflammation biology, at Millennium Pharmaceuticals in Cambridge, Massachusetts. In addition, he worked as a research scientist in the immunology department at the Glaxo Institute for Molecular Biology in Geneva, Switzerland.
He also has more than six years of experience as a post-doctoral research assistant in immunology and pharmacology at Institut Pasteur in Paris and the National Jewish Center of Immunology in Denver. ■